Natavia — Prenatal Genomics & Screening

Coming soon

Knowledge Before Birth. Confidence for the Journey.

A specialist reproductive genetics platform helping families understand inherited conditions through evidence-based education, compassionate counselling and access to appropriate testing.

Natavia is preparing to launch in Nigeria, focused first on sickle cell and inherited blood disorders. Nothing is bookable yet.

A serene expectant mother in an ivory gown, resting her hands on her belly in warm golden light

Sickle cell first

Preparing to launch

Results to the mother only

Screening, explained honestly

Services

What is coming

A specialist reproductive genetics platform helping families understand inherited conditions through evidence-based education, compassionate counselling and access to appropriate testing.

Flagship, launching first

Non-Invasive Prenatal Sickle Cell Screening

In development with our laboratory partner

A maternal blood sample, analysed by our specialist laboratory partner, can assess whether a baby is at risk of sickle cell disease and related haemoglobin disorders, without any procedure that reaches the baby.

This is a screening test, not a diagnosis.

Guidance

Genetic Counselling

Forming part of the launch service

Guidance before and after testing, with inheritance risk explained plainly and decisions supported without pressure.

You will have time to ask questions, consider your options, and decide in your own time.

Support first. Testing is always your choice.

Planned

Couples’ Genotype and Carrier Screening

In development

Confirming both parents’ genotypes, including AA, AS, AC and other variants, so risk is understood before pregnancy or early in pregnancy.

Confirmation matters, because an old or incorrect genotype report can change the picture completely.

This is a screening test, not a diagnosis.

Planned

Core Prenatal Screen

Planned

Chromosomal screening from a maternal blood sample, covering:

  • Trisomy 21 (Down syndrome)
  • Trisomy 18 (Edwards syndrome)
  • Trisomy 13 (Patau syndrome)

It can also tell the baby’s sex, if you wish to know.

This is a screening test, not a diagnosis.

Planned

Sex Chromosome Screening

Planned

An add-on to the Core Prenatal Screen, covering the sex chromosomes.

It is taken from the same blood sample, at the same time, so there is no second draw and nothing extra asked of you.

This is a screening test, not a diagnosis.

Planned

Non-Invasive Prenatal Paternity Test

Planned

Paternity established before birth, from the mother’s blood and a sample from the alleged father.

It is arranged only with the mother’s written consent, and the result is delivered to the mother alone.

This is a screening test, not a diagnosis. The mother’s written consent is always required first.

More panels will be added only as our laboratory partners validate them and confirm them in writing.

Sickle Cell & Genetics

Understanding inheritance

Sickle cell disease is one of the most common serious inherited conditions in Nigeria. More than 100,000 babies are born with it here every year, and about 300,000 pregnancies a year are at risk because both parents carry the trait.

Sources: NDHS 2018; Lancet Haematology 2021; UN birth estimates.

When both parents have genotype AS, these are the chances in every pregnancy, and each pregnancy is a new, independent event.

Trait is not disease

A carrier has sickle cell trait, for example genotype AS. Carriers are healthy. They do not have sickle cell disease, they do not develop it later, and most never know they carry the trait until they are tested.

When a child has SS

A child with genotype SS has sickle cell disease and needs lifelong care, regular follow up and prompt treatment when unwell. That is why knowing early matters: it gives parents and doctors time to prepare, plan care and protect the child from the very start.

Inheritance calculator

Choose both parents’ genotypes to see the possible outcomes for a child, in each pregnancy.

Educational only. This calculator explains inheritance chances; it is not a test and not a diagnosis.

How It Works

Five careful stages

From the first conversation to your results and guidance, everything is handled quietly and in order.

1

Speak with Natavia

We discuss your pregnancy stage, family history and parental genotype.

2

Review your screening options

Eligibility, benefits, limitations and alternatives, with counselling before you decide.

3

Provide a maternal blood sample

Collected using the approved collection kit and procedure. Nothing reaches your baby.

4

Specialist laboratory analysis

Your sample is sent to the approved partner laboratory under validated transport conditions.

5

Receive results and professional guidance

What the result means, and whether diagnostic confirmation or additional care is recommended.

Stages open to patients as each partnership is confirmed.

An expectant mother talking warmly with her doctor in a calm, sunlit clinic room

Our Promise

You come first, always

Privacy

Your results go to you. Never to family members, and never to anyone else.

Honesty

Screening is not diagnosis. A high-risk result always comes with a clear path back to your doctor or a genetic counsellor.

Care

You speak with a person, not just a report. We stay with you until your questions are answered.

For Healthcare Professionals

A careful partner for your patients

We are preparing Natavia with obstetricians, fertility specialists and hospitals in mind. If you care for women in pregnancy, or couples planning a pregnancy, we would value a clinical partnership built on clear eligibility, careful sampling and honest reporting.

Her results go to her, as she directs. We support your care; we do not replace it.

Being prepared for clinical partners

  • Patient referral pathway
  • Clinical eligibility criteria
  • Sample collection and shipping instructions
  • Report interpretation guidance
  • Genetic counselling referral pathway
Request clinical partnership information

Questions

Answered plainly

Honest answers, with no promise we cannot yet keep. Exact windows and specifications for each test will be confirmed at launch.

Can two AS parents have an AA baby?

Yes. In each pregnancy, two AS parents have a 25 percent chance of a child with AA, a 50 percent chance of AS, and a 25 percent chance of SS. Each pregnancy is independent.

What are the chances of having an SS baby?

It depends on both parents’ genotypes. When both parents are AS, the chance is 25 percent in each pregnancy. Use the calculator above to see the chances for other combinations.

Can a mother’s blood sample reveal fetal sickle cell risk?

Yes, that is the basis of the screening Natavia is developing with its specialist laboratory partner. Small amounts of the baby’s genetic material circulate in the mother’s blood, and validated analysis can assess fetal risk without a procedure that reaches the baby.

Does the test require the father’s blood?

The screening itself uses the mother’s blood. Confirming the father’s genotype helps interpret risk accurately, so his confirmed result may be requested. Where a father’s sample is needed for a specific test, what is required will be explained plainly before anything is arranged.

How early can screening begin?

Timing depends on the test. Prenatal paternity testing with our laboratory partner can begin from 7 weeks of pregnancy. Screening windows for each test will be confirmed at launch, and we will not publish a week we cannot stand behind.

Can the test identify HbSC?

HbSC is a form of sickle cell disease, from one S and one C variant. Whether a specific screening panel reports HbSC risk will be confirmed by our laboratory partner and stated clearly at launch.

Is the test safe for the pregnancy?

Non-invasive screening uses blood drawn from the mother’s arm. Nothing reaches the baby, and there is no procedure related risk to the pregnancy from the blood draw itself.

Does a high-risk result mean the baby definitely has sickle cell disease?

No. Screening assesses risk; it does not diagnose. A high-risk result should be followed by diagnostic confirmation, arranged through specialists, so you can plan with certainty.

What happens if the result is inconclusive?

Sometimes a sample does not give a clear answer. If that happens, you will be told plainly what it means, whether a redraw is appropriate, and what your other options are, with guidance at each step.

Will I need CVS or amniocentesis?

Not for screening. CVS and amniocentesis are diagnostic procedures, separate from screening, and are only considered if you want diagnostic confirmation after a high-risk result. They are arranged through qualified specialists, and the choice is always yours.

What if I am already 15 weeks pregnant?

Do not assume it is too late. Eligibility depends on the test and its confirmed window, which will be published at launch. Speak with your clinician in the meantime, and join our launch updates so you hear the confirmed details first.

What if my previous genotype report was wrong?

It happens, and it matters. Genotype confirmation is important because reports can be wrong, which is why Natavia confirms both parents rather than relying on an old report alone.

Can I decline testing?

Always. Testing is your choice. Counselling is there to help you decide, never to pressure you, and declining changes nothing about the respect and care you receive.

Who will see my results?

Only you, the mother. Your results are delivered to you alone, and shared further only as you direct.

What support is available if my baby is affected?

You will not be left with a result and no path. Support includes clear explanation of the result, genetic counselling, and referral to specialists who can plan care for you and your baby, including diagnostic confirmation where you choose it.

Privacy & Consent

Your information, protected

Genetic and health information is sensitive personal data under the Nigeria Data Protection Act, and Natavia will treat it that way from the first day.

Natavia will test only with the mother’s written consent. Results go to the mother alone. Samples and data will be transferred abroad only under a clear international transfer notice, explained before you consent.

The full privacy notice, consent documents and refund and redraw policy are being prepared and will be published before launch. Nothing will be collected or tested before those protections are in place.

Launch Updates

Be first to know when we open

Natavia is preparing to launch. Register for launch updates and we will write to you as services, screening windows and partnerships are confirmed. No booking is being taken yet.

Join launch updates by email

Write to hello@nataviahealth.com with the subject Launch updates. The mailbox activates before public launch.

Contact

Begin with a conversation

Our offices are in Lagos and Abuja. Write to us first, and we will answer your questions personally. Consultations and testing open at launch.

Lagos

Ikeja

Concord Building
42 Airport Road, Ikeja
Lagos, Nigeria

Abuja

Central Business District

The Chelsea Centre
123 Mohammadu Buhari Way
Central Business District, Abuja, Nigeria

Write to us

Write to us at hello@nataviahealth.com and we will reply personally.